Source link : https://www.newshealth.biz/health-news/gene-therapy-improves-motor-function-in-children-with-sma/
(Reuters) – Swiss drugmaker Novartis said on Monday its gene therapy helped improve motor function in children with a rare muscle disorder that leaves patients too weak to walk, talk and swallow. Novartis was testing the therapy, onasemnogene abeparvovec or OAV101 IT, in a late-stage trial of patients between the ages of 2 and less […]
Author : News Health
Publish date : 2024-12-30 16:01:06
Copyright for syndicated content belongs to the linked Source.
inHealth